These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 33202731)

  • 1. Not All Wnt Activation Is Equal: Ligand-Dependent versus Ligand-Independent Wnt Activation in Colorectal Cancer.
    Kleeman SO; Leedham SJ
    Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33202731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of RNF43 frameshift mutations that drive Wnt ligand- and R-spondin-dependent colon cancer.
    Yamamoto D; Oshima H; Wang D; Takeda H; Kita K; Lei X; Nakayama M; Murakami K; Ohama T; Takemura H; Toyota M; Suzuki H; Inaki N; Oshima M
    J Pathol; 2022 May; 257(1):39-52. PubMed ID: 35040131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of Wnt Receptor Turnover by R-spondin-ZNRF3/RNF43 Signaling Module and Its Dysregulation in Cancer.
    Hao HX; Jiang X; Cong F
    Cancers (Basel); 2016 Jun; 8(6):. PubMed ID: 27338477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular genetics and targeted therapy of WNT-related human diseases (Review).
    Katoh M; Katoh M
    Int J Mol Med; 2017 Sep; 40(3):587-606. PubMed ID: 28731148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploiting differential Wnt target gene expression to generate a molecular biomarker for colorectal cancer stratification.
    Kleeman SO; Koelzer VH; Jones HJ; Vazquez EG; Davis H; East JE; Arnold R; Koppens MA; Blake A; Domingo E; Cunningham C; Beggs AD; Pestinger V; Loughrey MB; Wang LM; Lannagan TR; Woods SL; Worthley D; Consortium SC; Tomlinson I; Dunne PD; Maughan T; Leedham SJ
    Gut; 2020 Jun; 69(6):1092-1103. PubMed ID: 31563876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive Analysis of R-Spondin Fusions and RNF43 Mutations Implicate Novel Therapeutic Options in Colorectal Cancer.
    Seeber A; Battaglin F; Zimmer K; Kocher F; Baca Y; Xiu J; Spizzo G; Novotny-Diermayr V; Rieder D; Puccini A; Swensen J; Ellis M; Goldberg RM; Grothey A; Shields AF; Marshall JL; Weinberg BA; Sackstein PE; Lim KH; Tan GS; Nabhan C; Korn WM; Amann A; Trajanoski Z; Berger MD; Lou E; Wolf D; Lenz HJ
    Clin Cancer Res; 2022 May; 28(9):1863-1870. PubMed ID: 35254413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RSPO3 expands intestinal stem cell and niche compartments and drives tumorigenesis.
    Hilkens J; Timmer NC; Boer M; Ikink GJ; Schewe M; Sacchetti A; Koppens MAJ; Song JY; Bakker ERM
    Gut; 2017 Jun; 66(6):1095-1105. PubMed ID: 27511199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RSPO3 antagonism inhibits growth and tumorigenicity in colorectal tumors harboring common Wnt pathway mutations.
    Fischer MM; Yeung VP; Cattaruzza F; Hussein R; Yen WC; Murriel C; Evans JW; O'Young G; Brunner AL; Wang M; Cain J; Cancilla B; Kapoun A; Hoey T
    Sci Rep; 2017 Nov; 7(1):15270. PubMed ID: 29127379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of WNT Pathway Mutations in Cancer Development and an Overview of Therapeutic Options.
    Groenewald W; Lund AH; Gay DM
    Cells; 2023 Mar; 12(7):. PubMed ID: 37048063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent PTPRK-RSPO3 fusions and RNF43 mutations in colorectal traditional serrated adenoma.
    Sekine S; Yamashita S; Tanabe T; Hashimoto T; Yoshida H; Taniguchi H; Kojima M; Shinmura K; Saito Y; Hiraoka N; Ushijima T; Ochiai A
    J Pathol; 2016 Jun; 239(2):133-8. PubMed ID: 26924569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploiting the Therapeutic Interaction of WNT Pathway Activation and Asparaginase for Colorectal Cancer Therapy.
    Hinze L; Labrosse R; Degar J; Han T; Schatoff EM; Schreek S; Karim S; McGuckin C; Sacher JR; Wagner F; Stanulla M; Yuan C; Sicinska E; Giannakis M; Ng K; Dow LE; Gutierrez A
    Cancer Discov; 2020 Nov; 10(11):1690-1705. PubMed ID: 32703769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological and molecular correlations in traditional serrated adenoma.
    Sekine S; Yamashita S; Yamada M; Hashimoto T; Ogawa R; Yoshida H; Taniguchi H; Kojima M; Ushijima T; Saito Y
    J Gastroenterol; 2020 Apr; 55(4):418-427. PubMed ID: 32052185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNF43 germline and somatic mutation in serrated neoplasia pathway and its association with BRAF mutation.
    Yan HHN; Lai JCW; Ho SL; Leung WK; Law WL; Lee JFY; Chan AKW; Tsui WY; Chan ASY; Lee BCH; Yue SSK; Man AHY; Clevers H; Yuen ST; Leung SY
    Gut; 2017 Sep; 66(9):1645-1656. PubMed ID: 27329244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EIF3E-RSPO2 and PIEZO1-RSPO2 fusions in colorectal traditional serrated adenoma.
    Hashimoto T; Ogawa R; Yoshida H; Taniguchi H; Kojima M; Saito Y; Sekine S
    Histopathology; 2019 Aug; 75(2):266-273. PubMed ID: 30916365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. R-spondin-3 is an oncogenic driver of poorly differentiated invasive breast cancer.
    Ter Steege EJ; Boer M; Timmer NC; Ammerlaan CM; Song JY; Derksen PW; Hilkens J; Bakker ER
    J Pathol; 2022 Nov; 258(3):289-299. PubMed ID: 36106661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological and molecular characteristics of RSPO fusion-positive colorectal cancer.
    Hashimoto T; Takayanagi D; Yonemaru J; Naka T; Nagashima K; Yatabe Y; Shida D; Hamamoto R; Kleeman SO; Leedham SJ; Maughan T; Takashima A; Shiraishi K; Sekine S
    Br J Cancer; 2022 Oct; 127(6):1043-1050. PubMed ID: 35715628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogenic mutations in adenomatous polyposis coli (Apc) activate mechanistic target of rapamycin complex 1 (mTORC1) in mice and zebrafish.
    Valvezan AJ; Huang J; Lengner CJ; Pack M; Klein PS
    Dis Model Mech; 2014 Jan; 7(1):63-71. PubMed ID: 24092877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Wnt Pathway Inhibitor RXC004 Blocks Tumor Growth and Reverses Immune Evasion in Wnt Ligand-dependent Cancer Models.
    Phillips C; Bhamra I; Eagle C; Flanagan E; Armer R; Jones CD; Bingham M; Calcraft P; Edmenson Cook A; Thompson B; Woodcock SA
    Cancer Res Commun; 2022 Sep; 2(9):914-928. PubMed ID: 36922934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive characterization of RSPO fusions in colorectal traditional serrated adenomas.
    Sekine S; Ogawa R; Hashimoto T; Motohiro K; Yoshida H; Taniguchi H; Saito Y; Yasuhiro O; Ochiai A; Hiraoka N
    Histopathology; 2017 Oct; 71(4):601-609. PubMed ID: 28543708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. R-spondins can potentiate WNT signaling without LGRs.
    Lebensohn AM; Rohatgi R
    Elife; 2018 Feb; 7():. PubMed ID: 29405118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.